Bausch Health Companies | VRX - Cash And Equivalent

Stock Price
7.01
Daily Change
-0.10 -1.41%
Monthly
-13.56%
Yearly
-30.11%
Q1 Forecast
6.65

Bausch Health Companies reported $1.31B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Amgen USD 9.13B 316M Dec/2025
ANI Pharmaceuticals USD 285.58M 22.98M Dec/2025
Aurora Cannabis CAD 95.69M 44.47M Sep/2025
Bausch Health Companies USD 1.31B 419M Sep/2025
Biogen USD 3.01B 854.3M Dec/2025
Bristol-Myers Squibb USD 10.21B 5.52B Dec/2025
Canopy Growth CAD 298.06M 171.86M Sep/2025
Corcept Therapeutics USD 120.49M 4.64M Dec/2025
Danaher USD 4.62B 3.09B Dec/2025
Drreddys Laboratories INR 18.66B 9.65B Dec/2025
Eli Lilly USD 7.27B 2.52B Dec/2025
Gilead Sciences USD 7.33B 2.19B Sep/2025
Nektar Therapeutics USD 41.03M 1.96M Sep/2025
Novo Nordisk A/S DKK 18.44B 5.78B Jun/2025
Pacira USD 158.54M 10.96M Dec/2025
Perrigo USD 432.1M 22.1M Sep/2025
Phibro Animal Health USD 55.49M 17.28M Dec/2025
Prestige Brands USD 62.37M 56.73M Dec/2025
Supernus Pharmaceuticals USD 151.37M 6.66M Sep/2025
Vertex Pharmaceuticals USD 6.61B 321.1M Dec/2025
Zoetis USD 2.08B 649M Sep/2025